FDA Approves Libtayo® for Locally Advanced and Metastatic Basal Cell CarcinomaThe U.S. Food and Drug Administration has approved Libtayo® (cemiplimab-rwlc) to treat certain types of locally advanced (cannot be removed by surgery) and metastatic (has spread) basal cell carcinoma (BCC).1... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
American Cancer Society Releases 2021 Report on CancerThe American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Risks for People with CancerEditor’s Note: This article was first published on August 20, 2020. Further developments in what we know about the coronavirus are continuously emerging. Cancer and its treatments can weaken the... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for... By Editorial Team4 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
What to Know About Cancer and COVID-19 (Coronavirus)The spread of the novel coronavirus, COVID-19, has changed our daily lives. But people with a higher risk for illness from COVID-19 are wondering what they can do to stay... By Editorial Team4 min readBookmark for later Reactions 0 reactions Comments0 comments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to... By Editorial Team4 min readBookmark for later Reactions 0 reactions Comments0 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial Team5 min readBookmark for later Reactions 0 reactions Comments0 comments
The American Cancer Society Issues 2020 Report on CancerThe American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017... By Editorial Team3 min readBookmark for later Reactions 0 reactions Comments1 comments
Take the Chronic Pain In America Survey! (Now Closed)This survey is now closed. Thank you to all our participants!We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
Project Facilitate to Increase Access to Compassionate Use TreatmentsFor some battling cancer, especially those with more advanced or aggressive cancers, approved or available treatment options may eventually become limited. When this happens, some may turn to clinical trials... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
Take The Clinical Trial Patient Voice Survey (Now Closed)Have you participated in a clinical trial? Are you interested in participating in future clinical trials? We want to hear more about your experience! SkinCancer.net/Health Union is teaming up with... By Editorial Team1 min readBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Keytruda for Advanced or Metastatic Merkel Cell CarcinomaThe U.S. Food and Drug Administration (FDA) has granted approval for Keytruda® (pembrolizumab) as a treatment for advanced or metastatic Merkel cell carcinoma in both adults and children.1Merkel cell carcinoma... By Emily Downward2 min readBookmark for later Reactions 0 reactions Comments2 comments
Research Shows Cancer Likely to Become More Deadly than Heart DiseaseHeart disease is the leading cause of death in Americans, but new research shows that cancer is likely to surpass heart disease as the number one killer in 2020, especially... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
New App Helps Dermatology Medical Students Detect Skin CancerOne of the biggest challenges that medical students (and even residents) face is lack of practical experience. While medical education is extensive, much of it is learned in classroom or... By Editorial Team2 min readBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Immunotherapy Drug Libtayo for Advanced Cutaneous Squamous Cell CarcinomaOn September 28, 2018, the U.S. Food and Drug Administration (FDA) approved Libtayo® (cemiplimab-rwlc) for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC). This approval is... By Emily Downward2 min readBookmark for later Reactions 0 reactions Comments0 comments
